Renoprotective Effect of the Recombinant Anti-IL-6R Fusion Proteins by Inhibiting JAK2/STAT3 Signaling Pathway in Diabetic Nephropathy
Diabetic nephropathy the main reason for end stage renal disease is a common microvascular complication in patients with type 1 and type 2 diabetes. The interleukin-6 (IL-6), acting as a pleiotropic cytokine, play key roles in main autoimmune disorders. The recombinant anti-IL-6R fusion proteins (VH...
Main Authors: | Nanwen Zhang, Qingmei Zheng, Yaduan Wang, Juan Lin, He Wang, Rui Liu, Mengru Yan, Xiaofeng Chen, Juhua Yang, Xiaole Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-05-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.681424/full |
Similar Items
-
ErHuang Formula Improves Renal Fibrosis in Diabetic Nephropathy Rats by Inhibiting CXCL6/JAK/STAT3 Signaling Pathway
by: Yu-Li Shen, et al.
Published: (2020-01-01) -
The role of local IL6/JAK2/STAT3 signaling in high glucose–induced podocyte hypertrophy
by: Hyung Ah Jo, et al.
Published: (2016-12-01) -
JAK-STAT in Early Hematopoiesis and Leukemia
by: Eirini Sofia Fasouli, et al.
Published: (2021-05-01) -
Mechanosignaling through Caveolae : A New Role for the Control of JAK-STAT Signaling
by: Tardif, Nicolas
Published: (2018) -
Pharmacological Effects of Polyphenol Phytochemicals on the JAK-STAT Signaling Pathway
by: Qianqian Yin, et al.
Published: (2021-09-01)